EGFR and head and neck squamous cell carcinoma: In HNSCC cells binding assay, 64Cu-PCTA-cetuximab demonstrated that cell bound radioactivity (%) was well correlated with the EGFR level of HNSCC cells evaluated by flow cytometry and western blot analysis (Figure 1a, 1b, and 1d).